Prevenção da diabetes/ Prevention of diabetes.
Artigo/ article na/in The Lancet.
"Rosiglitazone at 8 mg daily for 3 years substantially reduces incident type 2 diabetes and increases the likelihood of regression to normoglycaemia..."
"14 (0·5%) participants in the rosiglitazone group and two (0·1%) in the placebo group developed heart failure (p=0·01)."
Artigo/article na/in NEJM.
"...the use of ramipril for 3 years does not significantly reduce the incidence of diabetes or death but does significantly increase regression to normoglycemia."